TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2015 DA - 2015// TI - Cancer statistics, 2015 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21254 DO - 10.3322/caac.21254 ID - Siegel2015 ER - TY - STD TI - Dottino JA, Cliby WA, Myers ER, Bristow RE, Havrilesky LJ. Improving NCCN guideline-adherent care for ovarian cancer: value of an intervention. Gynecol Oncol. 2015. ID - ref2 ER - TY - JOUR AU - Doll, A. AU - Abal, M. AU - Rigau, M. AU - Monge, M. AU - Gonzalez, M. AU - Demajo, S. PY - 2008 DA - 2008// TI - Novel molecular profiles of endometrial cancer-new light through old windows JO - J Steroid Biochem Mol Biol VL - 108 UR - https://doi.org/10.1016/j.jsbmb.2007.09.020 DO - 10.1016/j.jsbmb.2007.09.020 ID - Doll2008 ER - TY - JOUR AU - McMeekin, D. S. AU - Filiaci, V. L. AU - Thigpen, J. T. AU - Gallion, H. H. AU - Fleming, G. F. AU - Rodgers, W. H. PY - 2007 DA - 2007// TI - The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a gynecologic oncology group study JO - Gynecol Oncol VL - 106 UR - https://doi.org/10.1016/j.ygyno.2007.04.032 DO - 10.1016/j.ygyno.2007.04.032 ID - McMeekin2007 ER - TY - BOOK AU - Davidson, B. F. J. AU - Clarke, L. H. PY - 2015 DA - 2015// TI - Tumor grade and chemotherapy response in endometrioid endometrial cancer ID - Davidson2015 ER - TY - JOUR AU - Krivak, T. C. AU - Lele, S. AU - Richard, S. AU - Secord, A. A. AU - Leath, C. A. AU - Brower, S. L. PY - 2014 DA - 2014// TI - A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer JO - Am J Obstet Gynecol VL - 211 UR - https://doi.org/10.1016/j.ajog.2014.02.009 DO - 10.1016/j.ajog.2014.02.009 ID - Krivak2014 ER - TY - JOUR AU - Rutherford, T. AU - Orr, J. AU - Grendys, E. AU - Edwards, R. AU - Krivak, T. C. AU - Holloway, R. PY - 2013 DA - 2013// TI - A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer JO - Gynecol Oncol VL - 131 UR - https://doi.org/10.1016/j.ygyno.2013.08.009 DO - 10.1016/j.ygyno.2013.08.009 ID - Rutherford2013 ER - TY - JOUR AU - Fleming, G. F. AU - Brunetto, V. L. AU - Cella, D. AU - Look, K. Y. AU - Reid, G. C. AU - Munkarah, A. R. PY - 2004 DA - 2004// TI - Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a gynecologic oncology group study JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.07.184 DO - 10.1200/JCO.2004.07.184 ID - Fleming2004 ER - TY - JOUR AU - Fleming, G. F. AU - Filiaci, V. L. AU - Bentley, R. C. AU - Herzog, T. AU - Sorosky, J. AU - Vaccarello, L. PY - 2004 DA - 2004// TI - Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a gynecologic oncology group study JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh316 DO - 10.1093/annonc/mdh316 ID - Fleming2004 ER - TY - JOUR AU - Thigpen, J. T. AU - Brady, M. F. AU - Homesley, H. D. AU - Malfetano, J. AU - DuBeshter, B. AU - Burger, R. A. PY - 2004 DA - 2004// TI - Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.02.088 DO - 10.1200/JCO.2004.02.088 ID - Thigpen2004 ER - TY - JOUR AU - Gallion, H. H. AU - Brunetto, V. L. AU - Cibull, M. AU - Lentz, S. S. AU - Reid, G. AU - Soper, J. T. PY - 2003 DA - 2003// TI - Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: a gynecologic oncology group study JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.10.083 DO - 10.1200/JCO.2003.10.083 ID - Gallion2003 ER - TY - JOUR AU - Thigpen, J. T. AU - Blessing, J. A. AU - Homesley, H. AU - Creasman, W. T. AU - Sutton, G. PY - 1989 DA - 1989// TI - Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a gynecologic oncology group study JO - Gynecol Oncol VL - 33 UR - https://doi.org/10.1016/0090-8258(89)90605-7 DO - 10.1016/0090-8258(89)90605-7 ID - Thigpen1989 ER - TY - JOUR AU - Ball, H. G. AU - Blessing, J. A. AU - Lentz, S. S. AU - Mutch, D. G. PY - 1996 DA - 1996// TI - A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a gynecologic oncology group study JO - Gynecol Oncol VL - 62 UR - https://doi.org/10.1006/gyno.1996.0227 DO - 10.1006/gyno.1996.0227 ID - Ball1996 ER - TY - JOUR AU - Previs, R. AU - Leath, C. A. AU - Coleman, R. L. AU - Herzog, T. J. AU - Krivak, T. C. AU - Brower, S. L. PY - 2015 DA - 2015// TI - Evaluation of in vitro chemoresponse profiles in women with type I and type II epithelial ovarian cancers: an observational study ancillary analysis JO - Gynecol Oncol VL - 138 UR - https://doi.org/10.1016/j.ygyno.2015.05.038 DO - 10.1016/j.ygyno.2015.05.038 ID - Previs2015 ER - TY - JOUR AU - Cancer Genome Atlas Research, N. AU - Kandoth, C. AU - Schultz, N. AU - Cherniack, A. D. AU - Akbani, R. AU - Liu, Y. PY - 2013 DA - 2013// TI - Integrated genomic characterization of endometrial carcinoma JO - Nature VL - 497 UR - https://doi.org/10.1038/nature12113 DO - 10.1038/nature12113 ID - Cancer Genome Atlas Research2013 ER - TY - JOUR AU - Marchio, C. AU - Filippo, M. R. AU - Ng, C. K. AU - Piscuoglio, S. AU - Soslow, R. A. AU - Reis-Filho, J. S. PY - 2015 DA - 2015// TI - PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas JO - Gynecol Oncol VL - 137 UR - https://doi.org/10.1016/j.ygyno.2015.02.010 DO - 10.1016/j.ygyno.2015.02.010 ID - Marchio2015 ER -